Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Medic Drugs Midterm
| Question | Answer |
|---|---|
| Morphine Sulfate (CLASS) | Narcotic Analgesic |
| Midazolam (CLASS) | Short Acting Benzodiazepine |
| Naloxone (CLASS) | Narcotic Antagonist |
| Dextrose 50% (CLASS) | Hyperglycemic Agent |
| Nitroglycerin (CLASS) | Vasodilator/Antianginal |
| Aspirin (CLASS) | Antiplatelet/NSAID/Non-Narcotic Analgesic |
| Adenosine (CLASS) | Antidysrhythmic |
| Epinephrine (CLASS) | Sympathomimetic |
| Atropine Sulfate (CLASS) | Parasympatholytic/Anticholinergic |
| Lidocaine (CLASS) | Antiarrythmic |
| Dopamine (CLASS) | Sympathomimetic |
| Albuterol (CLASS) | Bronchodilator (Beta 2 Adrenergic) |
| Furosemide (CLASS) | Diuretic |
| Morphine Sulphate (ACTION) (6) | 1.Binds to Opiate receptors in the SNS 2.Alters preception to pain 3.Systemic vasodilation (Decreases Pre/AfterLoads) 4.CNS Depressant 5.Analgesia 6.Anxiety relief |
| Midazolam (ACTION) (3) | 1.Anticonvulsant/CNS Depressant 2.Adjunct to intubation 3.Skeletal Muscle Relaxant |
| Naloxone (ACTION) (1) | Displaces narcotics from opiate receptor sights |
| Dextrose 50% (ACTION) (1) | Rapidly Raises Blood Glucose Levels |
| Nitroglycerin (ACTION) (3) | 1.Reduces myocardium o2 demands 2.Systemic Vasodilation (Reduces After/PreLoads) 3.Increased blood flow in collateral coronary vessels |
| Aspirin (ACTION) (1) | Inhibits platelet aggregation & vasoconstriction by blocking prostaglandin systhesis, which prevents the formation of the platelet aggregating substance thromboxane A2. |
| Adenosine (ACTION) (2) | 1. Slows conduction through AV node 2.Inhibits reentry pathways through AV & SA nodes |
| Epinephrine (ACTION) (4) | Stimulates adrenergic receptors 2.Alpha=Peripheral Vasoconstriction 3.Beta 1 = + Inotrope & Chronotrope 4.Beta 2 = Bronchodilation |
| Atropine Sulfate (ACTION) (4) | 1.Compet. inhibitor of AcH @ PNS Postganglionic fibers 2.Blocks vegal effect on SA node= + chrono., AV conduct, CO, & BP 3.GI Anticholinergic =Drying mucus membrane; Lower GI secretions, GI motility, Salavation,& Sweat 4.+intraocular press.=Pupil Dilation |
| Lidocaine (ACTION) (3) | 1.Increased fibrillatory threshold 2.Decreases ventricular irratability 3.Suppresses ventricular ectopy |
| Dopamine (ACTION) (4) | 1.Stimulate Dopaminergic Alpha & Beta receptor of SNS 2.LOW DOSE stimulate dopaminergic receptor(Renal & Mesenteric Vasodilation 2.MID DOSE stimulate Beta receptor(+ Inotrope effect) 4.HIGH DOSE stimulate Alpha receptor(Peripheral renal & mesen.Vasoconstr |
| Albuterol (ACTION) (1) | Bronchial smooth muscle dilation by Beta 2 receptors |
| Furosemide (ACTION) (2) | 1.Rapid acting sulfonamide loop diuretic 2.Vasodilation (Reduces After/PreLoad) |
| Morphine Sulfate (INDICATION) (3) | 1.Anginal CP 2.Pulmonary Edema 3.Severe Pain in isolated extremity Trauma & Burns |
| Midazolam (INDICATION) (4) | 1.Seizures 2.Adjunct to intubation 3.Sedation prior to cardio version 4.Chemical restraint |
| Naloxone (INDICATION) (2) | 1.OD of narcotics or their derivatives 2.Coma of unknown etiology |
| 12 narcotics or their derivatives | 1.Codine 2.Diphenoxylate(Lomotil) 3.Fetanyl(Sublimaze) 4.Heroin 5.Hydromorphone(Dilaudid) 6.Meperidine(Demerol) 7.Methadone(Dolophine) 8.Morphine 9.Oxycodone(Precodan) 10.Perigoric 11.Propoxyphine(Darvon) 12.Pentazocine(Talwin) |
| Dextrose 50% (INDICATION) (4) | 1.Unconscious diabetic Pt 2.Coma of unk etiology 3.Seizures w/ suspected hypoglycemia 4.<70 Blood Glucose level |
| Nitroglycerin (INDICATION) (3) | 1.Angina Pectoris 2.Pulmonary edema 3.Hypertensive crisis |
| Aspirin (INDICATION) (1) | S/S indicative of an MI |
| Adenosine (INDICATION) (2) | 1.SVT 2.PSVT |
| Epinephrine (INDICATION) (6) | W/O PULSE:1.Aystole 2.Idoventricular rhythm 3.V-Fib/V-Tach 4.PEA W/PULSE: 5.Anaphylaxis 6.Bronchospasm |
| Atropine Sulfate (INDICATION) (4) | 1.Symptomatic Bradycardia 2.Slow PEA 3.Asytole 4.Organophosphate poisoning |
| Lidocaine (INDICATION) (3) | 1.Malginant PVCs 2.V-Fib 3.V-Tach |
| Dopamine (INDICATION) (3) | 1.DOC for cardiogenic shock 2.Other states of shock after fluid resuscitation 3.Bradycardia w/ Hypotention |
| Albuterol (INDICATION) (5) | 1.Bronchospasm of any etiology 2.Asthma 3.COPD 4.Pulmonary Edema 5.Toxic inhalation |
| Furosemide (INDICATION) (2) | 1. CHF 2.Acute Pulmonary Edema |
| Morphine Sulfate (DOSE/ROUTE) (3) | 1.CP = 3-5mg slow IVP,MR q 5min to max of 10mg 2.Pulmonary Edema = 3-5mg slow IVP,MR q 5min to max of 10mg 3.Ortho Trauma/Burns = 3-5mg slow IVP / IM ,MR q 5min to max of 10mg Base contact required for more than 10mg |
| Midazolam (DOSE/ROUTE) (2) | 1. 0.1mg/kg SLOW IVP to a max of 5mg 2. 0.2mg/kg IM to a max of 10mg |
| Naloxone (DOSE/ROUTE) (2) | 2. 2mg RIVP; Use SL / IM if can't get IV, MR q 3-5min 2.Double dose for ET |
| Dextrose 50% (DOSE/ROUTE) (1) | 25g (50ml) IVP, MR x 1 |
| Nitroglycerin (DOSE/ROUTE) (1) | 0.4mg SL spray or tablet MR q 3-5min to a max of 3 doses |
| Aspirin (DOSE/ROUTE) (1) | 162mg PO |
| Adenosine (DOSE/ROUTE) (2) | 1.Initial dose 6mg bolus RIVP (<1-2sec) followed by a 10-20ml NS flush 2.After initial dose give 12mg bolus RIVP (<1-2sec) followed by a 10-20ml NS flush q 2min if no change |
| Epinephrine (DOSE/ROUTE) (4) | 1.Asthma = 0.3-0.5mg 1:1000 IM/SC, MR q5min to max of 2 dose 2.Allergic/Anaphylaxis = 0.3-0.5mg 1:1000 IM/SC, MR q 5-15min as needed 3.Cardiac Arrest = 1.0mg 1:10000 IVP, MR q 3-5min 4.Cardiac Arrest = 2.0 - 2.5mg ET 1:1000 MR q 3-5min |
| Atropine Sulfate (DOSE/ROUTE) (4) | 1.Bradycardias = 0.5mg RIVP, MR 0.5mg q 3-5min to max 0.04mg/kg 2.PEA = 1mg RIVP, 2mg ET; MR 1mg q 3-5min to max 0.04mg/kg 3.Asytole = 1mg RIVP, 2mg ET; MR 1mg q 3-5min to max 0.04mg/kg 4.Organophosphates = 2-4mg RIVP/ET; MR 2mg q 5 till asymptomatic |
| Lidocaine (DOSE/ROUTE) (4) | 1.Ventricular Ectopy & V-Tach = 1mg/kg SLOW IVP/ET MR 0.5mg/kg q 5-10min to max 3mg/kg 2.V-Fib = 1-1.5mg/kg IVP/ET MR 1-1.5mg/kg q 3-5min to max 3mg/kg 3.IV Infusion = 2g in 250cc D5W run @ 2-4mg/kg (2mg/min =15gtts/min) (4mg/min = 30gtts/min) |
| Dopamine (DOSE/ROUTE) (3) | 1. 5-20mcg/kg/min IV Infusion 2.Beta Stimulation = 5-10mcg/kg/min 3.Alpha Stimulation = >10mcg/kg/min |
| Albuterol (DOSE/ROUTE) (1) | 2.5mg in 3ml NS via HHN |
| Furosemide (DOSE/ROUTE) (1) | 40mg SLOW IVP |
| Morphine Sulphate (Onset/Duration) (2) | 1. 1min IV 2.10-15min IM |
| Midazolam (Onset/Duration) (2) | 1. 3-5min IV 2. 5-15min IM |
| Naloxone (Onset/Duration) (3) | 1. 1-2min IV, SL, ET 2. Slightly longer IM 3. Duration 30-60min |
| Dextrose 50% (Onset/Duration) (1) | Less than 1min |
| Nitroglycerin (Onset/Duration) (2) | 1. SL 1-2min 2.Duration 30min |
| Adenosine (Onset/Duration) (2) | 1.Onset 20-30sec 2.Half-life 10sec |
| Epinephrine (Onset/Duration) (2) | 1. IV/ET <2min 2.SC 3-10min |
| Atropine Sulfate (Onset/Duration) (1) | 1min IV |
| Lidocaine (Onset/Duration) (2) | 1. Onset 2min IV 2.Duration 10-20min |
| Furosemide (Onset/Duration) () | 5-10min |
| Morphine Sulphate (CONTRAINDICATION) (8) | 1.Hypersensitivity to opiates 2.Hypotension, Hypovolemia, Shock 3.Severe Resp. Depress. 4.Head Trauma 5.Diminished LOC 6.Multisystem trauma 7.Pain of Unk Etiology 8.Acute Ab Pain |
| Midazolam (CONTRAINDICATION) (7) | 1. Hypersensitivity to Versed 2.Hypovolemia, Hypotension, Shock 3.Coma 4.Acute narrow angle glaucoma 5.Acute ETOH intoxication 6.Depressed VS 7.Pregnancy |
| Naloxone (CONTRAINDICATION) (1) | Hypersensitivity to narcan |
| Dextrose 50% (CONTRAINDICATION) (1) | None in EMS setting |
| Nitroglycerin (CONTRAINDICATION) (4) | 1.Hypersensitivity to nitrates 2.Hypotension BP <90 3.S/S of ICP 4.Viagra w/in 24 or Cialas w/in 36 |
| Aspirin (CONTRAINDICATION) (3) | Hypersensitivity to Salcylics 2.Bleeding Disorders 3.CP associated w/ trauma |
| Adenosine (CONTRAINDICATION) (3) | 1. A-Fib/Flutter 2.V-Tach 3. Second & Third Degree Heart Block |
| Epinephrine (CONTRAINDICATION) (5) | 1.None in Cardiac Arrest 2.Underlying Cardiac Disease 3.Hypersensitivity to Sympathomimetics 4.Tachyarrhythmias, HTN 5.Hemorrhagic or Cardiogenic Shock |
| Atropine Sulfate (CONTRAINDICATION) (1) | None in energency setting |
| Lidocaine (CONTRAINDICATION) (4) | 1.PVCs w/ bradycardia 2.Second or Third Degree Heart Block 3.Idoventricular Rhythm 4.Allergy to amide type local anesthetics |
| Dopamine (CONTRAINDICATION) (2) | 1.Hypovolemic shock 2.Tachydysrhythmias |
| Albuterol (CONTRAINDICATION) (2) | 1.Allergy to albuterol 2.HTN |
| Furosemide (CONTRAINDICATION) (2) | 1.Pregnancy 2.Dehydration |
| Morphine Sulfate (Adverse Effects) (4) | CNS = Euphoria, Sedation, Confusion, Ataxia CV = Hypotension & Bradycardia Resp = Respiratory Depression GI = n/v |
| Midazolam (Adverse Effects) (3) | CNS = Sedation, Ataxia, Coma, Drowsiness CV = Hypotension Resp = Respiratory Depression, Apnea |
| Naloxone (Adverse Effects) (4) | CNS = Withdrawl s/s w/ rapid reversal, Combative behavior, Return of chronic Pain CV = Tachycardia,MI RESP = Tachypnea GI = N/V |
| Dextrose 50% (Adverse Effects) (1) | None in emergency setting |
| Nitroglycerine (Adverse Effects) (3) | CNS = h/a,dizziness CV = Orthostatic Hypotension, Tachycardia, Flushing, Palpations GI = N/V |
| Aspirin (Adverse Effects) (2) | EENT = tinnitus GI = N/V, GI Irritation |
| Adenosine (Adverse Effects) (4) | CNS = Blurred Vision, Burning sensation, dizziness, neck pain, tingling in arms CV = CP, facial flushing, hypotention, transient bradycardia, asystole GI = Metallic taste, nausea RESP = Hyperventilation |
| Epinephrine (Adverse Effects) (2) | CNS = h/a, anxiety, muscle tremmors CV = HTN, SVT, Ventricular irratability, palpitations, MI |
| Atropine Sulfate (Adverse Effects) (3) | CNS = h/a, restlessness, dizziness CV = increased HR & o2 demand, arrhythmias EENT = pupil dilation, worsens glacoma, dry mouth, thirst, thickened airway secretions |
| Lidocaine (Adverse Effects) (2) | EarlyS/S of Toxicity = restlessness, anxiety, disorientation,combativeness, twitching,numbness, euphoria Late S/S of toxicity = convulsions, coma, hypotention, wide QRS, long PRI, cardiac arrest |
| Dopamine (Adverse Effects) (3) | CNS = h/a CV = Vent. irritability, dysrhythmias, HTN-high dose, Hypotention-low dose GI = n/v |
| Albuterol (Adverse Effects) (3) | CNS = tremor, insomnia, h/a CV = tachycardia, hypertension, palpitations GI = n/v |
| Furosemide (Adverse Effects) (3) | CV = orthoststic hypotension, dehydration GI = n/v EENY = ototoxicity if injected too fast |
| Morphine Sulfate (PRECAUTION) (5) | 1.Have narcan & airway equip ready 2.Moniror EKG & VS @ regular intervals 3.Potentiates effects of ETOH/CNS depressants 4. Obtain Pt's pain level prior to each dose 5.Use w/ caution in very old or very young Pts |
| Midazolam (PRECAUTIONS) (5) | 1.Keep airway equip ready 2.Monitor VS & assess resp. continuously 3.Give IM injections i large muscle mass no deltoid 4.Resp depression w/ rapid injection 5.Potentiates effects of ETOH & CNS depressants |
| Naloxone (PRECAUTIONS) (4) | 1.Rapid reversal of OD may cause withdrawl S/S Titrate fr adiquate resp. 2.Monitor VS & EKG 3.High potential for relapse if Narcotic outlasts Narcan 4.Use w/ cautionin newborns w/ suspected drug exposure Hx |
| Dextrose 50% (PRECAUTIONS) (6) | 1.Record BG pre & post admin 2.Use large bore cathetern to start IV 3.Aspirate occasionally during admin 4.Sclerosing to internal tissues 5.May precipitate psychosis in alcoholics w/ thiamin deficiency 6.Use caution if suspected CVA or brain bleed |
| Nitroglycerin (PRECAUTIONS) (5) | Monitor VS (BP) & EKG 2.Use supp. o2 3.Anticipate throbbing h/a 4.Store in cool, dry, dark place 5.Do NOT shake spray |
| Aspirin (PRECAUTIONS) (1) | None when given for cardiac ischemia |
| Adenosine (PRECAUTIONS) (5) | 1.Use large proximal vein to start IV 2.Monitor EKG, HR,& BP q 15-30sec for several min post admin 3.Use supp o2 4.Solution must be clear discard if discolored 5.May cause bronchoconstriction in Pts w/ asthma |
| Epinephrine (PRECAUTIONS) (3) | 1. Monitor VS & EKG 2.Use supp o2 3.Potentiation may occure w/ sympathomimetics |
| Atropine Sulfate (PRECAUTIONS) (5) | 1.Monitor EKG 2.Use supp o2 3.Incompatable w/ bicarb & valium 4.Initial paradoxical bradycardia may occure when IV admin sowly or when less than 0.5mg is used 5.May worsen Myocardial ischemia in acute MI |
| Lidocaine (PRECAUTIONS) (4) | 1.Monitor EKG & VS 2.Look for ectopy & CNS toxicity 3.Use supp o2 4.STOP IV @ 1st sign of toxicity 5.Use cautiously & @ 1/2 dose if Pt is > 65 or has Hx of CHF or liver disease |
| Dopamine (PRECAUTIONS) (5) | 1.Monitor VS & EKG continously 2.Use supp o2 3.If unwanted rise in BP is seen STOP IV 4.Tissue necrosis on blown vein 5.incompatable w/ bicarb |
| Alburerol (PRECAUTIONS) (7) | 1.Monitor VS & EKG 2.Use sup o2 w/ HHN 3.Monitor 4 toxicity if used w/ sympathos 4.Beta-blockers work antagonistically 5.TCAs & MAOIs increase CV effects 6.Causess less cardiac stimulation than other sympathos, but use caution 7.Check lung sounds pre/post |
| Furosemide (PRECAUTIONS) (3) | 1.Monitor VS (BP) 2.Use supp o2 3.Check lung sounds pre/post admin |
| Morphine Sulfate (SUPPLIED) (1) | 10mg/ml tubex or vial |
| Midazolam (SUPPLIED) (2) | 1.10mg/10ml vial 2. 10mg/2ml vial |
| Naloxone (SUPPLIED) (1) | 2mg/2ml p-load or ampule |
| Dextrose 50% (SUPPLIED) (1) | 25g/50ml preload |
| Nirtoglycerin (SUPPLIED) (1) | 0.4mg spray or tablet |
| Aspirin (SUPPLIED) (2) | 81mg chewables or 325mg tablets |
| Adenosine (SUPPLIED) (2) | 1. 6mg/2ml vial or preload 2. 12mg/4ml preload |
| Epinephrine (SUPPLIED) (2) | 1. 1:10,000 - 1mg/10ml preload (0.1mg/ml) 2. 1:1000 - 1mg in a 30ml vial or 1mg in a 1ml ampule (1.0mg/ml) |
| Atropine Sulfate (SUPPLIED) (3) | (1) 1mg/10ml preload (2) 1mg/1ml vial (3) 8mg/20ml vial |
| Lidocaine (SUPPLIED) (5) | [1] 100mg/10mg preload [2] 100mg/5ml preload [3] 50mg/5ml preload [4] 2g/250ml premix [5] 2g/500ml premix |
| Dopamine (SUPPLIED) (1) | 400mg in 250ml D5W (1600mcg.ml) premix |
| Albuterol (SUPPLIED) (1) | 2.5mg/3ml NS |
| Furosemide (SUPPLIED) (1) | 10mg/ml in a 10ml ampule |
Created by:
rcathey